Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Current indications for the implantable cardioverter defibrillator [[electronic resource] /] / by Dirk Böcker, Lars Eckardt, Günter Breithardt
| Current indications for the implantable cardioverter defibrillator [[electronic resource] /] / by Dirk Böcker, Lars Eckardt, Günter Breithardt |
| Autore | Böcker Dirk |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2004 |
| Descrizione fisica | 1 online resource (102 p.) |
| Disciplina |
617.412059
617.4120592 |
| Altri autori (Persone) |
EckardtLars
BreithardtGünter |
| Collana | Clinical approaches to tachyarrhythmias |
| Soggetto topico |
Cardiovascular instruments, Implanted
Heart - Surgery Defibrillators Arrhythmia - Treatment |
| ISBN |
1-280-19722-6
9786610197224 0-470-76190-3 0-470-75079-0 1-4051-4618-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Evolution of guidelines for defibrillator therapy -- Background of ICD therapy -- Current indications for ICD therapy -- Legal implications of defibrillator guidelines. |
| Record Nr. | UNINA-9910830995403321 |
Böcker Dirk
|
||
| Malden, Mass., : Blackwell Futura, c2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Current indications for the implantable cardioverter defibrillator [[electronic resource] /] / by Dirk Böcker, Lars Eckardt, Günter Breithardt
| Current indications for the implantable cardioverter defibrillator [[electronic resource] /] / by Dirk Böcker, Lars Eckardt, Günter Breithardt |
| Autore | Böcker Dirk |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2004 |
| Descrizione fisica | 1 online resource (102 p.) |
| Disciplina |
617.412059
617.4120592 |
| Altri autori (Persone) |
EckardtLars
BreithardtGünter |
| Collana | Clinical approaches to tachyarrhythmias |
| Soggetto topico |
Cardiovascular instruments, Implanted
Heart - Surgery Defibrillators Arrhythmia - Treatment |
| ISBN |
1-280-19722-6
9786610197224 0-470-76190-3 0-470-75079-0 1-4051-4618-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Evolution of guidelines for defibrillator therapy -- Background of ICD therapy -- Current indications for ICD therapy -- Legal implications of defibrillator guidelines. |
| Record Nr. | UNINA-9910841217603321 |
|
Böcker Dirk
|
||
| Malden, Mass., : Blackwell Futura, c2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron
| Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2004 |
| Descrizione fisica | 1 online resource (526 p.) |
| Disciplina |
616.1/24
616.124 |
| Altri autori (Persone) | MaronBarry J <1941-> (Barry Joel) |
| Soggetto topico | Heart - Hypertrophy |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-19730-7
9786610197309 0-470-79903-X 0-470-98746-4 1-4051-4615-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Diagnosis and Management of Hypertrophic Cardiomyopathy; Contents; Foreword; Dedication and Acknowledgments; List of Contributors; 1 Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy; 2 Genetic Mutations that Remodel the Heart in Hypertrophic Cardiomyopathy; 3 Genetic Basis and Genotype-Phenotype Relationships in Familial Hypertrophic Cardiomyopathy; 4 Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
5 Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management6 Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy; 7 Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy; 8 Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance; 9 Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions 10 Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy11 Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy; 12 Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression; 13 Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy; 14 Pharmacologic Treatment of Symptomatic Hypertrophic Cardiomyopathy; 15 Obstructive Hypertrophic Cardiomyopathy: Results of Septal Myectomy 16 United States Perspectives on the Role of Dual-Chamber Pacing in Patients with Hypertrophic Cardiomyopathy17 Dual-Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy; 18 Alcohol Septal Ablation; 19 Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven-Year Experience; 20 Role of Septal Ablation in a Surgical Center; 21 Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy; 22 Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy: Extreme Left Ventricular Hypertrophy as a New Indicator of Risk 23 Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy24 Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and Not So Benign Arrhythmias; 25 The Athlete's Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies; 26 Importance of Congenital Coronary Artery Anomalies 27 Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program |
| Record Nr. | UNINA-9910143294503321 |
| Malden, Mass., : Blackwell Futura, c2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron
| Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2004 |
| Descrizione fisica | 1 online resource (526 p.) |
| Disciplina |
616.1/24
616.124 |
| Altri autori (Persone) | MaronBarry J <1941-> (Barry Joel) |
| Soggetto topico | Heart - Hypertrophy |
| ISBN |
1-280-19730-7
9786610197309 0-470-79903-X 0-470-98746-4 1-4051-4615-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Diagnosis and Management of Hypertrophic Cardiomyopathy; Contents; Foreword; Dedication and Acknowledgments; List of Contributors; 1 Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy; 2 Genetic Mutations that Remodel the Heart in Hypertrophic Cardiomyopathy; 3 Genetic Basis and Genotype-Phenotype Relationships in Familial Hypertrophic Cardiomyopathy; 4 Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
5 Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management6 Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy; 7 Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy; 8 Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance; 9 Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions 10 Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy11 Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy; 12 Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression; 13 Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy; 14 Pharmacologic Treatment of Symptomatic Hypertrophic Cardiomyopathy; 15 Obstructive Hypertrophic Cardiomyopathy: Results of Septal Myectomy 16 United States Perspectives on the Role of Dual-Chamber Pacing in Patients with Hypertrophic Cardiomyopathy17 Dual-Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy; 18 Alcohol Septal Ablation; 19 Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven-Year Experience; 20 Role of Septal Ablation in a Surgical Center; 21 Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy; 22 Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy: Extreme Left Ventricular Hypertrophy as a New Indicator of Risk 23 Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy24 Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and Not So Benign Arrhythmias; 25 The Athlete's Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies; 26 Importance of Congenital Coronary Artery Anomalies 27 Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program |
| Record Nr. | UNISA-996214611603316 |
| Malden, Mass., : Blackwell Futura, c2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron
| Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2004 |
| Descrizione fisica | 1 online resource (526 p.) |
| Disciplina |
616.1/24
616.124 |
| Altri autori (Persone) | MaronBarry J <1941-> (Barry Joel) |
| Soggetto topico | Heart - Hypertrophy |
| ISBN |
1-280-19730-7
9786610197309 0-470-79903-X 0-470-98746-4 1-4051-4615-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Diagnosis and Management of Hypertrophic Cardiomyopathy; Contents; Foreword; Dedication and Acknowledgments; List of Contributors; 1 Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy; 2 Genetic Mutations that Remodel the Heart in Hypertrophic Cardiomyopathy; 3 Genetic Basis and Genotype-Phenotype Relationships in Familial Hypertrophic Cardiomyopathy; 4 Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
5 Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management6 Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy; 7 Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy; 8 Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance; 9 Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions 10 Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy11 Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy; 12 Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression; 13 Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy; 14 Pharmacologic Treatment of Symptomatic Hypertrophic Cardiomyopathy; 15 Obstructive Hypertrophic Cardiomyopathy: Results of Septal Myectomy 16 United States Perspectives on the Role of Dual-Chamber Pacing in Patients with Hypertrophic Cardiomyopathy17 Dual-Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy; 18 Alcohol Septal Ablation; 19 Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven-Year Experience; 20 Role of Septal Ablation in a Surgical Center; 21 Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy; 22 Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy: Extreme Left Ventricular Hypertrophy as a New Indicator of Risk 23 Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy24 Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and Not So Benign Arrhythmias; 25 The Athlete's Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies; 26 Importance of Congenital Coronary Artery Anomalies 27 Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program |
| Record Nr. | UNINA-9910830565003321 |
| Malden, Mass., : Blackwell Futura, c2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron
| Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2004 |
| Descrizione fisica | 1 online resource (526 p.) |
| Disciplina |
616.1/24
616.124 |
| Altri autori (Persone) | MaronBarry J <1941-> (Barry Joel) |
| Soggetto topico | Heart - Hypertrophy |
| ISBN |
1-280-19730-7
9786610197309 0-470-79903-X 0-470-98746-4 1-4051-4615-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Diagnosis and Management of Hypertrophic Cardiomyopathy; Contents; Foreword; Dedication and Acknowledgments; List of Contributors; 1 Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy; 2 Genetic Mutations that Remodel the Heart in Hypertrophic Cardiomyopathy; 3 Genetic Basis and Genotype-Phenotype Relationships in Familial Hypertrophic Cardiomyopathy; 4 Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
5 Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management6 Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy; 7 Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy; 8 Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance; 9 Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions 10 Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy11 Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy; 12 Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression; 13 Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy; 14 Pharmacologic Treatment of Symptomatic Hypertrophic Cardiomyopathy; 15 Obstructive Hypertrophic Cardiomyopathy: Results of Septal Myectomy 16 United States Perspectives on the Role of Dual-Chamber Pacing in Patients with Hypertrophic Cardiomyopathy17 Dual-Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy; 18 Alcohol Septal Ablation; 19 Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven-Year Experience; 20 Role of Septal Ablation in a Surgical Center; 21 Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy; 22 Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy: Extreme Left Ventricular Hypertrophy as a New Indicator of Risk 23 Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy24 Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and Not So Benign Arrhythmias; 25 The Athlete's Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies; 26 Importance of Congenital Coronary Artery Anomalies 27 Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program |
| Record Nr. | UNINA-9910841067503321 |
| Malden, Mass., : Blackwell Futura, c2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug induced movement disorders [[electronic resource] /] / edited by Stewart A. Factor, Anthony E. Lang, William J. Weiner
| Drug induced movement disorders [[electronic resource] /] / edited by Stewart A. Factor, Anthony E. Lang, William J. Weiner |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2005 |
| Descrizione fisica | 1 online resource (482 p.) |
| Disciplina | 616.8/3 |
| Altri autori (Persone) |
FactorStewart A. <1956->
LangAnthony E WeinerWilliam J |
| Soggetto topico |
Tardive dyskinesia
Antipsychotic drugs - Side effects Neuroleptic malignant syndrome Antiparkinsonian agents - Side effects |
| ISBN |
1-282-34982-1
9786612349829 0-470-76141-5 0-470-75321-8 1-4051-3755-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Movement disorders: approach, definitions and differential diagnosis / Martin Cloutier, Anthony E. Lang -- Rating scales for movement disorders / Ikwunga Wonodi ... [et al.] -- Spontaneous movement disorders in psychiatric patients / Irene Richard, Christopher O'Brien, Roger Kurlan -- Pharmacology of typical and atypical agents / Gary Remington, Shitij Kapur -- Acute drug-induced dystonia / Michael F. Mazurek, Patricia I. Rosebush -- Drug-induced Parkinsonism / Joseph H. Friedman, Martha E. Trieschmann, Hubert H. Fernandez -- Acute akathisia / Lenard A. Adler, John Rotrosen, Burt Angrist -- Neuroleptic malignant syndrome / Stewart A. Factor -- Classical tardive dyskinesia / Thomas M. Hyde ... [et al.] -- Tardive dyskinesia variants / Skidmore F, William J. Weiner, Burke R -- Movement disorders caused by atypical antipsychotics / Karen E. Anderson -- Commentary: is tardive dyskinesia disappearing? / James B. Lohr -- Dyskinesia induced by levodopa and dopamine agonists in Parkinson's disease / John G. Nutt, Matthew Brodsky -- Stimulant drugs / Anthony E. Munson, Juan Sanchez-Ramos, William J Weiner -- Antidepressants / Marie L. Moro-de-Casillas, David E. Riley -- Anticonvulsants / John C. Morgan, Madeline B. Harrison -- Miscellaneous drugs / Daniel Tarsy. |
| Record Nr. | UNINA-9910145593203321 |
| Malden, Mass., : Blackwell Futura, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug induced movement disorders [[electronic resource] /] / edited by Stewart A. Factor, Anthony E. Lang, William J. Weiner
| Drug induced movement disorders [[electronic resource] /] / edited by Stewart A. Factor, Anthony E. Lang, William J. Weiner |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2005 |
| Descrizione fisica | 1 online resource (482 p.) |
| Disciplina | 616.8/3 |
| Altri autori (Persone) |
FactorStewart A. <1956->
LangAnthony E WeinerWilliam J |
| Soggetto topico |
Tardive dyskinesia
Antipsychotic drugs - Side effects Neuroleptic malignant syndrome Antiparkinsonian agents - Side effects |
| ISBN |
1-282-34982-1
9786612349829 0-470-76141-5 0-470-75321-8 1-4051-3755-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Movement disorders: approach, definitions and differential diagnosis / Martin Cloutier, Anthony E. Lang -- Rating scales for movement disorders / Ikwunga Wonodi ... [et al.] -- Spontaneous movement disorders in psychiatric patients / Irene Richard, Christopher O'Brien, Roger Kurlan -- Pharmacology of typical and atypical agents / Gary Remington, Shitij Kapur -- Acute drug-induced dystonia / Michael F. Mazurek, Patricia I. Rosebush -- Drug-induced Parkinsonism / Joseph H. Friedman, Martha E. Trieschmann, Hubert H. Fernandez -- Acute akathisia / Lenard A. Adler, John Rotrosen, Burt Angrist -- Neuroleptic malignant syndrome / Stewart A. Factor -- Classical tardive dyskinesia / Thomas M. Hyde ... [et al.] -- Tardive dyskinesia variants / Skidmore F, William J. Weiner, Burke R -- Movement disorders caused by atypical antipsychotics / Karen E. Anderson -- Commentary: is tardive dyskinesia disappearing? / James B. Lohr -- Dyskinesia induced by levodopa and dopamine agonists in Parkinson's disease / John G. Nutt, Matthew Brodsky -- Stimulant drugs / Anthony E. Munson, Juan Sanchez-Ramos, William J Weiner -- Antidepressants / Marie L. Moro-de-Casillas, David E. Riley -- Anticonvulsants / John C. Morgan, Madeline B. Harrison -- Miscellaneous drugs / Daniel Tarsy. |
| Record Nr. | UNINA-9910808078403321 |
| Malden, Mass., : Blackwell Futura, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug induced movement disorders [[electronic resource] /] / edited by Stewart A. Factor, Anthony E. Lang, William J. Weiner
| Drug induced movement disorders [[electronic resource] /] / edited by Stewart A. Factor, Anthony E. Lang, William J. Weiner |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2005 |
| Descrizione fisica | 1 online resource (482 p.) |
| Disciplina | 616.8/3 |
| Altri autori (Persone) |
FactorStewart A. <1956->
LangAnthony E WeinerWilliam J |
| Soggetto topico |
Tardive dyskinesia
Antipsychotic drugs - Side effects Neuroleptic malignant syndrome Antiparkinsonian agents - Side effects |
| ISBN |
1-282-34982-1
9786612349829 0-470-76141-5 0-470-75321-8 1-4051-3755-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Movement disorders: approach, definitions and differential diagnosis / Martin Cloutier, Anthony E. Lang -- Rating scales for movement disorders / Ikwunga Wonodi ... [et al.] -- Spontaneous movement disorders in psychiatric patients / Irene Richard, Christopher O'Brien, Roger Kurlan -- Pharmacology of typical and atypical agents / Gary Remington, Shitij Kapur -- Acute drug-induced dystonia / Michael F. Mazurek, Patricia I. Rosebush -- Drug-induced Parkinsonism / Joseph H. Friedman, Martha E. Trieschmann, Hubert H. Fernandez -- Acute akathisia / Lenard A. Adler, John Rotrosen, Burt Angrist -- Neuroleptic malignant syndrome / Stewart A. Factor -- Classical tardive dyskinesia / Thomas M. Hyde ... [et al.] -- Tardive dyskinesia variants / Skidmore F, William J. Weiner, Burke R -- Movement disorders caused by atypical antipsychotics / Karen E. Anderson -- Commentary: is tardive dyskinesia disappearing? / James B. Lohr -- Dyskinesia induced by levodopa and dopamine agonists in Parkinson's disease / John G. Nutt, Matthew Brodsky -- Stimulant drugs / Anthony E. Munson, Juan Sanchez-Ramos, William J Weiner -- Antidepressants / Marie L. Moro-de-Casillas, David E. Riley -- Anticonvulsants / John C. Morgan, Madeline B. Harrison -- Miscellaneous drugs / Daniel Tarsy. |
| Record Nr. | UNISA-996203968303316 |
| Malden, Mass., : Blackwell Futura, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Endothelial dysfunctions and vascular disease [[electronic resource] /] / edited by Raffaele De Caterina, Peter Libby ; foreword by Michael A. Gimbrone Jr
| Endothelial dysfunctions and vascular disease [[electronic resource] /] / edited by Raffaele De Caterina, Peter Libby ; foreword by Michael A. Gimbrone Jr |
| Pubbl/distr/stampa | Malden, MA, : Blackwell Futura, 2007 |
| Descrizione fisica | 1 online resource (432 p.) |
| Disciplina | 616.1/3 |
| Altri autori (Persone) |
De CaterinaR. <1954->
LibbyPeter |
| Soggetto topico |
Blood-vessels - Pathophysiology
Vascular endothelium |
| ISBN |
1-281-32011-0
9786611320119 0-470-98481-3 0-470-98847-9 0-470-99409-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Endothelial Dysfunctions and Vascular Disease; Contents; Contributors; Preface; Foreword; Acknowledgments; Dedication; Part I: The basis of endothelial involvement in vascular diseases; 1 Endothelial functions and dysfunctions; 2 Endothelial activation and the initiation of atherosclerosis; 3 Mechanisms of plaque progression and complications; 4 Angiogenesis in cardiovascular disease; Part II: The endothelium and cardiovascular risk factors; 5 VLDL and atherosclerosis; 6 High-density lipoprotein and atheroprotection
7 Advanced glycation endproducts and the accelerated atherosclerosis in diabetes8 Homocysteine and endothelial dysfunction; 9 Lipoprotein(a) and the artery wall; 10 Oxidative stress and vascular disease; 11 Infections and vascular disease; Part III: Diagnostic tools and markers of endothelial functions; 12 Endothelial vasodilatory dysfunction: basic concepts and practical implementation; 13 Endothelial vasodilatory dysfunction and risk factors in adults; 14 Endothelial vasodilatory dysfunction in early life; 15 Endothelial vasodilatory dysfunction in hypertension 16 Vascular function and diabetes mellitus17 Dyslipidemia and endothelial dysfunction: pathophysiology and therapy; 18 Soluble adhesion molecules as in vivo biohumoral markers of vascular cell activation; Part IV: Endothelium-directed prevention and therapy; 19 Hormone replacement therapy and cardiovascular disease; 20 Anti-atherogenic effects of omega-3 fatty acids; 21 Treatment of endothelial dysfunction and atherosclerosis by cholesterol lowering; 22 Antioxidants and endothelial protection 23 Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers to reverse endothelial dysfunction24 PPARs in atherosclerosis; 25 Stem cells in atherosclerosis and atherosclerosisrelated vascular disorders; 26 Endothelium-targeted gene and cell-based therapy for cardiovascular disease; Index |
| Record Nr. | UNINA-9910145737103321 |
| Malden, MA, : Blackwell Futura, 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
